UNSPSC 51283504: Nafcillin

This classification denotes a beta-lactam antibiotic with the molecular formula C21H22N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4CNZ27M7RV, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo- but generally known as nafcillin, which bears US NIH Compound Identifier 8982. European Medicines Agency schedules Nafcillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09118MIG.

UNSPSC 51283504 Nafcillin is a Commodity code nominally identifying a specific pharmaceutical product, but recent state and local procurement activity under this code shows substantial mismatch — solicitations tagged to it span naloxone acquisition, direct-to-manufacturer prescription programs, fire department medical supplies, and multistate generic pharmaceutical contracting, none of which center on nafcillin itself. State and local governments buying under this code are primarily acquiring naloxone and drug deactivation systems for public health response, medical and first aid consumables for emergency services, and establishing framework agreements for generic pharmaceuticals and OTC products through cooperative purchasing vehicles. The issuing bodies include county health departments, city fire departments, state health and human services agencies, and multistate purchasing alliances; geographic activity centers on Florida, Texas, and Minnesota, with cooperative purchasing extending to Oregon and potentially broader state participation through MMCAP.

Recent opportunities illustrate the scope divergence. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023 (note: date inconsistency in source). The City of Tampa issued IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with a $700,000 estimated contract value and an SLBE set-aside designation offering a 5% bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 seeking generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026, and awards effective July 1, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription programs, representing early-stage market intelligence rather than a binding solicitation. The code's actual procurement value lies in understanding cooperative and direct-purchase models for pharmaceutical supply chains rather than tracking nafcillin-specific demand.